Immunogen | Devedores Comerciais



Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Astellas Pharma JPY 810.23B 75.43B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Exelixis USD 286.92M 24.38M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 67.04M 6.9M 2024-09
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
MacroGenics USD 69.23M 56.7M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Novartis USD 8.98B 192M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 186.13M 2025-12


Immunogen Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.